![Stephane Wong](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Stephane Wong
Keine laufenden Positionen mehr
Karriereverlauf von Stephane Wong
Ehemalige bekannte Positionen von Stephane Wong
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
MolecularMD Corp.
![]() MolecularMD Corp. Medical/Nursing ServicesHealth Services MolecularMD Corp. develops and commercializes molecular diagnostics for oncology applications. Its tests are designed to assist pharmaceutical companies with selection, monitoring and management of patients treated with molecularly-targeted cancer therapies. The firm integrates gold-standard and innovative platform technologies with custom clinical assay design and validation to accelerate all phases of clinical development, including FDA approval and commercialization of in vitro companion diagnostic tests for novel anticancer agents. The company was founded by Brian Druker, Sheridan G. Snyder, and Chad D. Galderisi in 2005 and is headquartered in Portland, OR. | Geschäftsführer | - | 16.02.2010 |
Technik-/Wissenschafts-/F&E-Leiter | 16.02.2010 | 01.09.2012 | |
Upstate USA, Inc. | Präsident | - | - |
Ausbildung von Stephane Wong
University of California, Los Angeles | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 4 |
Operativ
Chief Operating Officer | 1 |
Chief Tech/Sci/R&D Officer | 1 |
Doctorate Degree | 1 |
Sektoral
Health Services | 2 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
MolecularMD Corp.
![]() MolecularMD Corp. Medical/Nursing ServicesHealth Services MolecularMD Corp. develops and commercializes molecular diagnostics for oncology applications. Its tests are designed to assist pharmaceutical companies with selection, monitoring and management of patients treated with molecularly-targeted cancer therapies. The firm integrates gold-standard and innovative platform technologies with custom clinical assay design and validation to accelerate all phases of clinical development, including FDA approval and commercialization of in vitro companion diagnostic tests for novel anticancer agents. The company was founded by Brian Druker, Sheridan G. Snyder, and Chad D. Galderisi in 2005 and is headquartered in Portland, OR. | Health Services |
Upstate USA, Inc. |
- Börse
- Insiders
- Stephane Wong
- Erfahrung